Cuprina Holdings (Cayman) Limited (CUPR)
NASDAQ · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Financial statements, TTM figures and earnings dates
In fiscal year 2025 (ended December 31, 2025), Cuprina Holdings (Cayman) Limited reported revenue of SGD 49.9K and net income of −SGD 4.7M. Annual financial statements are available for fiscal years 2022 to 2025, taken from the company's filings with the SEC.
Open interactive financials →Key financials
| SGD | FY2025 2025-12-31 | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | SGD 49.9K | SGD 48.3K | SGD 100.8K | SGD 56.6K |
| Gross profit | −SGD 645 | −SGD 3.0K | SGD 36.6K | SGD 20.0K |
| Operating income | −SGD 4.8M | −SGD 1.6M | −SGD 1.1M | −SGD 1.2M |
| Net income | −SGD 4.7M | −SGD 1.6M | −SGD 1.1M | −SGD 1.1M |
| Diluted EPS | −SGD 22.83 | −SGD 8.68 | −SGD 6.22 | −SGD 6.08 |
| Cash flow | ||||
| Operating cash flow | −SGD 9.1M | −SGD 1.2M | −SGD 895.0K | −SGD 1.8M |
| Capital expenditure | SGD 58.2K | SGD 21.9K | SGD 68.0K | SGD 16.0K |
| Free cash flow | −SGD 9.2M | −SGD 1.3M | −SGD 963.0K | −SGD 1.9M |
| Balance sheet | ||||
| Cash and equivalents | SGD 3.1M | SGD 116.5K | SGD 35.3K | – |
| Total assets | SGD 8.5M | SGD 1.7M | SGD 1.6M | – |
| Total liabilities | SGD 3.4M | SGD 6.2M | SGD 4.5M | – |
| Total debt | SGD 164.9K | SGD 219.0K | – | – |
| Shareholders' equity | SGD 5.1M | −SGD 4.5M | −SGD 3.0M | −SGD 1.8M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SGD as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full CUPR page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open CUPR financials →